Health Minister JP Nadda reviewed the Indian Pharmacopoeia Commission (IPC), praising its role in ensuring drug quality and contributing to 'Atmanirbhar Bharat' and 'Viksit Bharat'. He noted the Indian Pharmacopoeia is now recognized in 19 countries.
Union Minister of Health and Family Welfare, Jagat Prakash Nadda today reviewed the progress and initiatives of the Indian Pharmacopoeia Commission (IPC) in the presence of Nivedita Shukla Verma, Secretary, Department of Chemicals and Petrochemicals (DoCP), who also holds the additional charge as Secretary, MoHFW.
According to the Ministry of Health and Family Welfare, Nadda appreciated IPC's sustained efforts in strengthening pharmacopoeial standards and pharmacovigilance activities, which contribute to the Government's vision of Atmanirbhar Bharat and a Viksit Bharat, promoting self-reliance, scientific excellence, and robust healthcare standards.
IPC's Pivotal Role in Public Health
During the review, JP Nadda commended IPC for its pivotal role in ensuring the quality, safety, and efficacy of medicines, thereby protecting public health. He noted that the Indian Pharmacopoeia remains a critical scientific and regulatory reference, ensuring uniform standards of medicines across the country.
Growing Global Recognition
The Minister highlighted that "the Indian Pharmacopoeia is now recognised in 19 countries, reflecting growing international confidence in India's regulatory and scientific capabilities." He observed that "this recognition strengthens India's position as the Pharmacy of the World and underscores the credibility of Indian pharmacopoeial standards globally."
In addition to this, the 10th edition of the Indian Pharmacopoeia 2026 is scheduled to be launched by the Union Health Minister in the first week of January 2026.
Emphasis on Patient Safety and Self-Reliance
In the meeting, Shri Nadda emphasised IPC's crucial role in implementing the Pharmacovigilance Programme of India (PvPI) to monitor adverse drug reactions and ensure patient safety and appreciated its efforts to strengthen reporting systems and build capacity among healthcare professionals. He also lauded IPC's contribution to Atmanirbhar Bharat through strengthening indigenous scientific expertise and regulatory standards while supporting global public health.
Directives for Future Growth
The Minister encouraged IPC to continue to focus on innovation, digitalisation, and global harmonisation of standards, in line with the vision of Viksit Bharat, to ensure universal access to safe, high-quality medicines.
The details of the activities were presented by Dr V Kalaiselvan, Secretary-cum-Scientific Director (IPC) and he further reaffirmed the commitment to strengthen pharmacopoeial and pharmacovigilance standards further, enhancing international collaboration and contributing to national and global health objectives.
Harsh Mangla, Joint Secretary, MoHFW and other senior officers of the Ministry were also present at the meeting. (ANI)
(Except for the headline, this story has not been edited by Asianet Newsable English staff and is published from a syndicated feed.)